Home Amines 331770-21-9
331770-21-9,MFCD13191283
Catalog No.:AA01EP9G

331770-21-9 | N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$165.00   $115.00
- +
5mg
≥98%
in stock  
$682.00   $477.00
- +
10mg
≥98%
in stock  
$1,192.00   $834.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA01EP9G
Chemical Name:
N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide
CAS Number:
331770-21-9
Molecular Formula:
C23H20N4O3
Molecular Weight:
400.4299
MDL Number:
MFCD13191283
SMILES:
COc1cc2c(ncnc2cc1OC)Nc1ccc(cc1)NC(=O)c1ccccc1
Properties
Properties
 
Form:
Solid  

Computed Properties
 
Complexity:
549  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
6  
XLogP3:
4.2  

Literature

Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.

Journal: The Biochemical journal 20130415

Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.

Journal: Nature biotechnology 20111101

Title: A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Journal: Proceedings of the National Academy of Sciences of the United States of America 20071218

Title: Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring.

Journal: Journal of medicinal chemistry 20060810

Title: SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20060301

Title: Andrew A Mortlock, et al. Progress in the development of selective inhibitors of aurora kinases. Curr Top Med Chem. 2005;5(8):807-21.

Title: Nicola M Heron, et al. SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1320-3.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 331770-21-9
Tags:331770-21-9 Molecular Formula|331770-21-9 MDL|331770-21-9 SMILES|331770-21-9 N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide